New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study

Figure 5 Receiver operating characteristic curves of the alpha-fetoprotein studied to differentiate between the hepatocellular carcinoma and chronic liver disease groups/malignant and non-malignant groups. A: Receiver operating characteristic (ROC) curve to assess the validity of alpha-fetoprotein (AFP) for the differentiation between the hepatocellular carcinoma and chronic liver disease groups; B: ROC curve assessing the validity of AFP for differentiating between the malignant and non-malignant groups. ROC: Receiver operating characteristic.